牛牛AI助理已提取核心訊息
On February 8, 2024, Doximity, Inc., a leading digital platform for U.S. medical professionals, reported its financial results for the fiscal quarter ending December 31, 2023. The company announced a 17% year-over-year increase in revenue to $135.3 million, with net income growing by 43% to $48.0 million, resulting in a net income margin of 35%. Adjusted EBITDA also saw a significant increase of 32% compared to the previous year, reaching $73.3 million. Doximity's diluted net income per share rose from $0.16 to $0.24, and non-GAAP diluted net income per share increased from $0.22 to $0.29. The company's operating cash flow and free cash flow both experienced a 3% year-over-year increase. Looking ahead, Doximity provided guidance for its fiscal fourth quarter with revenue expected to be between $115.9 million and...Show More
On February 8, 2024, Doximity, Inc., a leading digital platform for U.S. medical professionals, reported its financial results for the fiscal quarter ending December 31, 2023. The company announced a 17% year-over-year increase in revenue to $135.3 million, with net income growing by 43% to $48.0 million, resulting in a net income margin of 35%. Adjusted EBITDA also saw a significant increase of 32% compared to the previous year, reaching $73.3 million. Doximity's diluted net income per share rose from $0.16 to $0.24, and non-GAAP diluted net income per share increased from $0.22 to $0.29. The company's operating cash flow and free cash flow both experienced a 3% year-over-year increase. Looking ahead, Doximity provided guidance for its fiscal fourth quarter with revenue expected to be between $115.9 million and $116.9 million, and adjusted EBITDA projected between $50.5 million and $51.5 million. The company also updated its full fiscal year guidance, anticipating revenues between $473.3 million and $474.3 million, and adjusted EBITDA between $224.5 million and $225.5 million. Doximity's CEO, Jeff Tangney, expressed pride in the company's double-digit engagement growth and the continued daily use of their clinical workflow tools by doctors. The company now serves 17 of the top 22 U.S. hospitals as enterprise software clients.
2024年2月8日，面向美國醫療專業人員的領先數字平台Doximity, Inc. 公佈了截至2023年12月31日的財季財務業績。該公司宣佈收入同比增長17％，達到1.353億美元，淨收入增長43％，達到4,800萬美元，淨收入利潤率爲35％。調整後的息稅折舊攤銷前利潤也比上年大幅增長了32％，達到7,330萬美元。Doximity的攤薄後每股淨收益從0.16美元增至0.24美元，非公認會計准則攤薄後的每股淨收益從0.22美元增至0.29美元。該公司的運營現金流和自由現金流均同比增長3％。展望未來，Doximity爲其第四財季提供了指導，收入預計在1.159億美元至1.169億美元之間，調整...展開全部
2024年2月8日，面向美國醫療專業人員的領先數字平台Doximity, Inc. 公佈了截至2023年12月31日的財季財務業績。該公司宣佈收入同比增長17％，達到1.353億美元，淨收入增長43％，達到4,800萬美元，淨收入利潤率爲35％。調整後的息稅折舊攤銷前利潤也比上年大幅增長了32％，達到7,330萬美元。Doximity的攤薄後每股淨收益從0.16美元增至0.24美元，非公認會計准則攤薄後的每股淨收益從0.22美元增至0.29美元。該公司的運營現金流和自由現金流均同比增長3％。展望未來，Doximity爲其第四財季提供了指導，收入預計在1.159億美元至1.169億美元之間，調整後的息稅折舊攤銷前利潤預計在5,050萬美元至5,150萬美元之間。該公司還更新了完整的財年預期，預計收入在4.733億美元至4.743億美元之間，調整後的息稅折舊攤銷前利潤在2.245億美元至2.255億美元之間。Doximity的首席執行官傑夫·坦尼對該公司的兩位數參與度增長以及醫生每天持續使用其臨床工作流程工具表示自豪。該公司現在作爲企業軟件客戶爲美國排名前22位的醫院中的17家提供服務。
有用
沒用